KMS Medisurgi has scheduled its 28th Annual General Meeting for September 30, 2026, to approve FY26 financials and declare a final dividend of ₹0.05 per equity share. The record date for the payout is September 23, 2026.

The company confirmed that its register of members and share transfer books will remain closed from September 24, 2026 to September 30, 2026 (both days inclusive). This closure facilitates the determination of shareholders eligible for the dividend payment for the year ended March 31, 2026.

Agenda Highlights

The ordinary business for the AGM includes three primary resolutions:

• Adoption of the standalone financial statements, including the Statement of Profit & Loss and Cash Flow Statement for the year ended March 31, 2026.
• Declaration of a final dividend of ₹0.05 (0.5%) per equity share for FY26.
• Reappointment of Mr. Rohan Devang Kanakia as a director liable to retire by rotation.

Director Profile

Mr. Rohan Devang Kanakia, who holds a Master’s degree in Supply Chain Management, brings over eight years of experience to the board. He has been instrumental in driving the company’s export business and streamlining its supply chain operations.

He attended five board meetings during the year. Mr. Kanakia is the brother of Managing Director Siddharth Kanakia and Monali Kanakia, and the nephew of Gaurang Kanakia and Anand Kanakia. He currently holds no shares in the company.

Voting Procedures

The company has enabled remote e-voting through KfinTech. The facility will be available from 9:00 am on September 27, 2026 to 5:00 pm on September 29, 2026. Shareholders holding securities in demat mode can access the voting system via NSDL or CDSL portals.

Physical shareholders must register with KfinTech to obtain login credentials. Corporate members are required to submit certified copies of board resolutions authorizing their representatives to vote.

M/s. Naveen Karn & Co., Practising Company Secretary, has been appointed as the scrutinizer for the voting process.

KMS Medisurgi has scheduled a Board of Directors meeting for September 5, 2026. The gathering will focus on approving the financial statements for the fiscal year ended March 31, 2026.

The company informed the Bombay Stock Exchange about the upcoming session on August 27, 2026. This disclosure aligns with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Agenda Highlights

The board will transact several key items during the session. These include:

• Approving the Directors' Report for FY26
• Recommending the Financial Statements for member adoption
• Considering the Management Discussion and Analysis Report
• Deciding on the final dividend recommendation for equity shares
• Setting dates for the closure of the Register of Members and Share Transfer Books

Additionally, the board will appoint a Scrutinizer for the voting process at the 28th Annual General Meeting. The directors will also determine the day, date, time, and venue for convening this AGM.

Procedural Details

Siddharth Kanakia, Managing Director of KMS Medisurgi, signed the intimation letter. The company is headquartered in Mumbai. No financial figures were disclosed in this preliminary notice.